Pembrolizumab for head and neck cancer
1 Views
administrator
07/06/23
Visit http://www.ecancer.org
Dr Tanguy Seiwert (University of Chicago, Chicago, USA) presents the results of a 132-patient study that indicates that pembrolizumab immunotherapy is effective for patients with recurrent or metastatic head and neck cancer (HNC) during a press conference at ASCO 2015.
-
Category
Show more
Facebook Comments
No comments found